⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Collibra Named Databricks' Governance Partner of the Year; Collibra and Databricks Deepening a Partnership to Ground Agentic AI in Governed Context
prnewswire.com
RIVN
MA
BABA
UBER
CMG
ADI
AMZN
GOOG
MSFT
NVDA
CRM
PYPL
IBM
INTC
ADBE
NFLX
HON
GE
BA
CAT
UNH
PEP
KO
MCD
COST
WMT
TMO
ABBV
XOM
CVX
JPM
BAC
WFC
C
GS
MS
DIS
CMCSA
VZ
T
SBUX
NKE
MDT
AMGN
GILD
BMY
PFE
MRK
JNJ
PG
LMT
RTX
GD
LRCX
MU
AMD
QCOM
TXN
AVGO
AMAT
KLAC
ASML
ENPH
CRSP
REGN
VRTX
BIIB
AZN
SNY
LLY
BNTX
XCUR
ALGN
TDOC
ZBRA
ROKU
UL
Liberty All-Star® Growth Fund, Inc. May 2026 Monthly Update
businesswire.com
NVDA
AAPL
GOOGL
MSFT
AMZN
MPWR
NVT
STRL
CDTX
CW
HGV
DDOG
LLY
META
TPR
Process Industries Converge in Houston for Inaugural ChemE Show 2026 Powered by ACHEMA
prnewswire.com
XOM
JNJ
LLY
LIN
FRO
APD
ETR
AA
PH
Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026
prnewswire.com
LLY
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
prnewswire.com
LLY
Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
prnewswire.com
LLY
HTX Releases May Performance Report: TradFi Monthly Trading Volume Surpasses $1 Billion, While Multi-Front Progress Rebuilds Ecosystem Confidence
globenewswire.com
AMD
AVGO
QCOM
ARM
NFLX
JPM
LLY
12 Press Releases You Need to See This Week
prnewswire.com
LLY
ChronicleBio Is Coming for Chronic Disease: Pioneering Immunologist Joins Elite Scientific Team to Translate Biological Signal into Targeted Therapeutics
prnewswire.com
LLY
Antibody Partnering Surges into 2026: Q1 Deals Top $36 Billion as Bispecifics and Discovery Platforms Drive Competition
globenewswire.com
ABBV
LLY
MRK
NVS
PFE
SNY
GILD
BMY
JNJ
UCB